摘要
背景:糖尿病(DM)的发病率不断增加,伴随着微血管和大血管并发症,它与全球高发病率和死亡率负担有关。糖尿病病理生理学的主要组成部分包括糖毒性、脂毒性和胰岛素抵抗,扰乱血管壁完整性并导致内皮功能障碍和血小板过度聚集。 目的:本综述旨在鉴定和总结新型抗糖尿病药物(胰高血糖素样肽-1受体激动剂、二肽基肽酶-4抑制剂、钠-葡萄糖协同转运蛋白-2抑制剂)对内皮(EF)和血小板的影响。功能 (PF) 并评估与心血管结局研究结果的一致性。 方法:我们对 PubMed 数据库进行了结构化搜索,以获取 1981 年至 2020 年间关于 DM 和新型抗糖尿病药物对 EF 和 PF 影响的文献的同行评审研究。 结果:我们分析了有关新型抗糖尿病药物对 EF 和 PF 的影响以及 DM、PF 和 EF 之间病理生理学相互作用的数据。现有的研究使用不同的方法来评估这些结果,并且由于不同的研究设计、测试的药物组合、小研究样本和患者群体的异质性,不同研究的结果相当矛盾。 结论:目前可用的数据并不能明确支持新型抗糖尿病药物对 EF 和 PF 的一致影响。理想情况下,需要进一步研究以验证具有临床结果的结果。
关键词: 内皮功能障碍、血小板过度聚集、糖尿病、GLP-1 受体激动剂、DPP-4 抑制剂、SGLT-2 抑制剂、抗糖尿病药物、内皮。
Current Medicinal Chemistry
Title:Endothelial Dysfunction and Platelet Hyperaggregation in Type 2 Diabetes Mellitus: The Era of Novel Anti-diabetic Agents
Volume: 28 Issue: 20
关键词: 内皮功能障碍、血小板过度聚集、糖尿病、GLP-1 受体激动剂、DPP-4 抑制剂、SGLT-2 抑制剂、抗糖尿病药物、内皮。
摘要:
Background: The incidence of diabetes mellitus (DM) is ever-increasing and along with its microvascular and macrovascular complications, it is associated with a high morbidity and mortality burden globally. Major components of diabetes pathophysiology include glucotoxicity, lipotoxicity and insulin resistance, disturbing the vascular wall integrity and leading to endothelial dysfunction and platelet hyper aggregation.
Objective: This review aims to identify and summarize the effect of novel anti-diabetic agents (glucagon-like peptide-1 receptor agonists, dipeptidyl peptidase-4 inhibitors, sodium-glucose co-transporter -2 inhibitors) on endothelial (EF) and platelet function (PF) and evaluate the consistency with the results of cardiovascular outcomes studies.
Methods: We performed a structured search of the PubMed database for peer-reviewed research of the literature between 1981 and 2020 regarding the effect of DM and novel antidiabetic agents on EF and PF.
Results: We analyzed data regarding the effect of novel anti-diabetic agents on EF and PF as well as the pathophysiological interplay between DM, PF, and EF. The available studies use different methods to evaluate these outcomes and the results of different studies are rather conflicting as a result of different study designs, combinations of drugs tested, small study samples and patient population heterogeneity.
Conclusion: The currently available data do not unequivocally support a consistent effect of novel antidiabetic agents on EF and PF. Further study is required ideally for the validation of the results with clinical outcomes.
Export Options
About this article
Cite this article as:
Endothelial Dysfunction and Platelet Hyperaggregation in Type 2 Diabetes Mellitus: The Era of Novel Anti-diabetic Agents, Current Medicinal Chemistry 2021; 28 (20) . https://dx.doi.org/10.2174/0929867327666201009143816
DOI https://dx.doi.org/10.2174/0929867327666201009143816 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effects of ACE-Inhibitors and Angiotensin Receptor Blockers on Inflammation
Current Pharmaceutical Design Conductance and Resistance Vessels in Arterial Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Evaluating the Risk of Covid-19 Transmission from Conjunctival and Lacrimal Discharge: A Review
Current Biotechnology Cyclosporin A: A Therapeutic Strategy in Allergic Diseases
Letters in Drug Design & Discovery Neurotrophic Factors - A Tool for Therapeutic Strategies in Neurological,Neuropsychiatric and Neuroimmunological Diseases?
Current Medicinal Chemistry Vasospastic Angina and Ca Channel Blockers
Current Hypertension Reviews Neuropeptides and Gastric Mucosal Homeostasis
Current Topics in Medicinal Chemistry Investigation of Cytotoxic Effects of Oxymetazoline on Lungs in a Rat Model of Rhinitis Medicamentosa
Current Molecular Pharmacology The Effect of Serotonin 5-HT2 Receptor Inhibitor on Vasomotor Responses
Vascular Disease Prevention (Discontinued) Family History and Preclinical Atherosclerosis
Current Hypertension Reviews Effect of Androgenic and Antiandrogenic Acting Compounds in Macrophage Accumulation and Cell Replication in the Aorta of Oophorectomized Hypercholesterolemic Rabbits
Vascular Disease Prevention (Discontinued) Anatomical and Functional Relationships Between Sensory Nerves and Mast Cells
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Impact of Asymmetric Dimethylarginine (ADAMA), the Endogenous Nitric Oxide (NO) Synthase Inhibitor, to the Pathogenesis of Gastric Mucosal Damage
Current Pharmaceutical Design The Role of Heat Shock Protein 90 and Endothelial Nitric Oxide Synthase Signaling in Cardiovascular Therapy
Current Signal Transduction Therapy Adenosine Myocardial Perfusion Imaging
Current Medical Imaging The Role of Endothelial Related Circulating Biomarkers in COVID-19. A Systematic Review and Meta-analysis
Current Medicinal Chemistry Diffuse Correlation Spectroscopy (DCS): A Diagnostic Tool for Assessing Tissue Blood Flow in Vascular-Related Diseases and Therapies
Current Medical Imaging Anabolic Androgenic Steroid (AAS) Related Deaths: Autoptic, Histopathological and Toxicological Findings
Current Neuropharmacology Recent Advances on Nitric Oxide in the Upper Airways
Current Medicinal Chemistry Adiponectin and Cardiovascular Disease: Mechanisms and New Therapeutic Approaches
Current Medicinal Chemistry